Correlation Between Foghorn Therapeutics and Pharvaris

Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Foghorn Therapeutics and Pharvaris BV, you can compare the effects of market volatilities on Foghorn Therapeutics and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Pharvaris.

Diversification Opportunities for Foghorn Therapeutics and Pharvaris

0.51

Correlation Coefficient

Foghorn Therapeutics  Pharvaris

Very weak diversification

The 3 months correlation between Foghorn and Pharvaris is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Pharvaris go up and down completely randomly.

Pair Corralation between Foghorn Therapeutics and Pharvaris

Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Pharvaris. In addition to that, Foghorn Therapeutics is 1.46 times more volatile than Pharvaris BV. It trades about -0.03 of its total potential returns per unit of risk. Pharvaris BV is currently generating about 0.02 per unit of volatility. If you would invest  1,580  in Pharvaris BV on February 24, 2025 and sell it today you would earn a total of  19.00  from holding Pharvaris BV or generate 1.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Foghorn Therapeutics  vs.  Pharvaris BV

Foghorn Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Foghorn Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pharvaris BV

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Pharvaris is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Foghorn Therapeutics and Pharvaris

The main advantage of trading using opposite Foghorn Therapeutics and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.

The idea behind Foghorn Therapeutics and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.